Visterra secures exclusive patent license for promising dengue virus ... News-Medical.net "We are very pleased to license these promising dengue virus antibodies from MIT, and we are focused on rapidly developing a product candidate for this global and devastating infectious disease for which there is currently no preventive or therapeutic ... Visterra Acquires Antibody Family from MIT Visterra gets $8M to advance flu drug, acquires dengue drug |
